Literature DB >> 12761158

The stereochemistry of the amino acid side chain influences the inflammatory potential of muramyl dipeptide in experimental meningitis.

P Cottagnoud1, C M Gerber, P A Majcherczyk, F Acosta, M Cottagnoud, K Neftel, P Moreillon, M G Täuber.   

Abstract

Intrathecal injections of 50 to 100 micro g of (N-acetylmuramyl-L-alanyl-D-isoglutamine) muramyl dipeptide (MDP)/rabbit dose-dependently triggered tumor necrosis factor alpha (TNF-alpha) secretion (12 to 40,000 pg/ml) preceding the influx of leukocytes in the subarachnoid space of rabbits. Intrathecal instillation of heat-killed unencapsulated R6 pneumococci produced a comparable leukocyte influx but only a minimal level of preceding TNF-alpha secretion. The stereochemistry of the first amino acid (L-alanine) of the MDP played a crucial role with regard to its inflammatory potential. Isomers harboring D-alanine in first position did not induce TNF-alpha secretion and influx of leukocytes. This stereospecificity of MDPs was also confirmed by measuring TNF-alpha release from human peripheral mononuclear blood cells stimulated in vitro. These data show that the inflammatory potential of MDPs depends on the stereochemistry of the first amino acid of the peptide side chain and suggest that intact pneumococci and MDPs induce inflammation by different pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12761158      PMCID: PMC155715          DOI: 10.1128/IAI.71.6.3663-3666.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Induction of meningeal inflammation by diverse bacterial cell walls.

Authors:  E Tuomanen; B Hengstler; O Zak; A Tomasz
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

2.  Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis.

Authors:  E Tuomanen; B Hengstler; R Rich; M A Bray; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

3.  Digestion of Streptococcus pneumoniae cell walls with its major peptidoglycan hydrolase releases branched stem peptides carrying proinflammatory activity.

Authors:  P A Majcherczyk; H Langen; D Heumann; M Fountoulakis; M P Glauser; P Moreillon
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

Review 4.  New perspectives on bacterial meningitis.

Authors:  V J Quagliarello; W M Scheld
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

5.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.

Authors:  A Yoshimura; E Lien; R R Ingalls; E Tuomanen; R Dziarski; D Golenbock
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

Review 6.  The pathophysiology of pneumococcal meningitis.

Authors:  B Spellerberg; E I Tuomanen
Journal:  Ann Med       Date:  1994-12       Impact factor: 4.709

7.  Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives.

Authors:  R G Dacey; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

8.  Acute bacterial meningitis in adults. A review of 493 episodes.

Authors:  M L Durand; S B Calderwood; D J Weber; S I Miller; F S Southwick; V S Caviness; M N Swartz
Journal:  N Engl J Med       Date:  1993-01-07       Impact factor: 91.245

9.  The induction of meningeal inflammation by components of the pneumococcal cell wall.

Authors:  E Tuomanen; H Liu; B Hengstler; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.

Authors:  J D Baumgartner; D Heumann; J Gerain; P Weinbreck; G E Grau; M P Glauser
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.